| Theme | ACLF & Liver Transplantation: Who Makes the Cut? |
| Date & Time | 21 Nov, Friday 12:20 - 12:45 Hrs |
| Location | Hall A |
| Role | Moderator |
| Genre | Panel Discussion |
| Topic | Case-Based Panel Discussion |
| Theme | Unravelling the prophylactic intricacies in Immunosuppressed |
| Date & Time | 22 Nov, Saturday 11:10 - 11:35 Hrs |
| Location | Hall A |
| Role | Panelist |
| Genre | Panel Discussion |
| Topic | Case based Panel Discussion |
| Date & Time | 20th Nov Thursday 10:00-10:15 Hrs |
| Location | Hall B |
| Role | Speaker |
| Genre | Didactic Talk |
| Topic | Pre-op Optimization in CLD: Practical Tips II - POPH, HPS and Cardiac dysfunction |
| Theme | Unravelling the prophylactic intricacies in Immunosuppressed |
| Date & Time | 22 Nov 2025 ? 11:10 - 11:35 |
| Location | Hall A |
| Role | Panelist |
| Topic | Case based Panel Discussion: Alcoholic ACLF presenting with MELD 37 (after initial admission in local unit), proc al 2.5, blood c/s- no growth and TLC 20000/mm3, planned for an ABOi Liver Transplantation Sub-topics: 1. How should the elevated TLC be interpreted in the context of ACLF? Is it indicative of an infection not detected by blood culture, or could it be related to the severe inflammation associated with ACLF? 2. In ALF we start prophylactic antibiotics and anti-fungal: Does same holds true for ACLF, High MELD 3. What role do other inflammatory markers (e.g., CRP, procalcitonin) play in guiding management decisions in this patient? Practice in Panelists unit |